FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

WAREHAM JOHN P 		2. Issuer Name and Ticker or Trading Symbol

RESMED INC [ RMD ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

761 MISSION CREEK DRIVE 		3. Date of Earliest Transaction (MM/DD/YYYY)

5/24/2019
(Street)

PALM SPRINGS, CA 92211
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
ResMed Common Stock   5/24/2019     M    11085   A $51.25   24085   D    
ResMed Common Stock   5/24/2019     S    11085   D $113.435   (1) 13000   D    
ResMed Common Stock   5/24/2019     M    9628   A $51.25   22628   D    
ResMed Common Stock   5/24/2019     S    9628   D $114.00   13000   D    
ResMed Common Stock   5/24/2019     M    23629   A $52.02   36629   D    
ResMed Common Stock   5/24/2019     S    23629   D $114.00   13000   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
ResMed Common Stock Options   $51.25   5/24/2019     M         11085    11/11/2016   (2) 11/13/2020   ResMed Common Stock   11085   $0   9628   D    
ResMed Common Stock Options   $51.25   5/24/2019     M         9628    11/11/2016   (2) 11/13/2020   ResMed Common Stock   9628   $0   0   D    
ResMed Common Stock Options   $52.02   5/24/2019     M         23629    11/11/2015   (2) 11/19/2021   ResMed Commmon Stock   23629   $0   0   D    

Explanation of Responses:
(1)  This transaction was executed in multiple trades at prices ranging from $113.44 to $113.45. The price reported above reflects the weighted average sale price.
(2)  Represents date options first became exercisable. Options vest on the earlier of (i) the first November 11 following the Grant Date, or (ii) the date of the first (1st) annual meeting of stockholders of the Company following the Grant Date.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
WAREHAM JOHN P
761 MISSION CREEK DRIVE
PALM SPRINGS, CA 92211 		X



Signatures
John P. Wareham 5/28/2019
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Resmed Inc CDI (PK) (USOTC:RSMDF)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Resmed Inc CDI (PK) Charts.
Resmed Inc CDI (PK) (USOTC:RSMDF)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Resmed Inc CDI (PK) Charts.